ONO-1110-06:A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients with Hunner Type Interstitial Cystitis

Ono Pharmaceutical Co.,LTD0 个研究点目标入组 50 人开始时间: 2025年4月2日最近更新: 2025年6月2日

试验速览

暂无简介。

•Japanese (both sexes)
•Age (at the time of informed consent): 18 years and older
•Patients who are considered capable of understanding the study procedures and completing the pain diary, bladder diary, and questionnaires appropriately by the investigator (sub-investigator)
•Patients given a diagnosis of HIC by cystoscopy
•Patients with chronic pelvic pain involving the bladder and lower urinary tract symptoms such as increased micturition and pollakiuria

•Patients with a history and presence of chemical cystitis
•Patients with a history of bladder augmentation or radical cystectomy
•Patients with pain other than HIC that may affect assessments in this study
•Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
•Patients receiving medications for psychiatric disease

发起方